Cargando…
Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)
PURPOSE: To quantify gastrointestinal stromal tumor (GIST) patients’ preferences for reducing treatment toxicities and the likely effect of toxicities on patients’ stated adherence. METHODS: English-speaking members of the Life Raft Group, a GIST patient advocacy and research organization, aged 18 y...
Autores principales: | Hauber, A Brett, Gonzalez, Juan Marcos, Coombs, John, Sirulnik, Andres, Palacios, David, Scherzer, Norman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140312/ https://www.ncbi.nlm.nih.gov/pubmed/21792302 http://dx.doi.org/10.2147/PPA.S20445 |
Ejemplares similares
-
Epidemiology, survival, and costs of localized gastrointestinal stromal tumors
por: Rubin, Jaime L, et al.
Publicado: (2011) -
Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
por: Ghias, Adnan Asif Parvez, et al.
Publicado: (2018) -
Primary omental Gastrointestinal stromal tumor (GIST)
por: Todoroki, Takeshi, et al.
Publicado: (2007) -
LAPAROSCOPIC RESECTION OF GASTROINTESTINAL STROMAL TUMORS (GIST)
por: LOUREIRO, Marcelo de Paula, et al.
Publicado: (2016) -
Profile of patients with gastrointestinal stromal tumors
(GIST)
por: PRACUCHO, Eduardo Marcucci, et al.
Publicado: (2015)